Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China（IVTIS）

ID
Name
SWMU-2023-12
Description
This study aims to observe the safety and effectiveness of intravenous thrombolysis for acute ischemic stroke in real-world clinical practice.
Trial arms
Trial start
2023-11-20
Estimated PCD
2045-12-15
Trial end
2046-05-01
Status
Recruiting
Treatment
intravenous thrombolysis
Intravenous thrombolysis using thrombolytic drugs such as ateplase and teneplase.
Arms:
Acute ischemic stroke treated with intravenous thrombolysis
Size
3000
Primary endpoint
modified Rankin Scale (mRS) score
90±7 days
Eligibility criteria
Inclusion Criteria: * The patient was diagnosed with acute ischemic stroke and received intravenous thrombolysis. Exclusion Criteria: * No additional exclusion criteria.
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 3000, 'type': 'ESTIMATED'}}
Updated at
2023-11-28

1 organization

1 product

2 indications

Organization
Zhengzhou Yuan
Product
Intravenous Thrombolysis
Indication
stroke
Indication
Acute